Monthly Archives: March 2019

Biothera Pharmaceuticals to Participate in Webinar on Utilizing Innate Immune Mechanisms to Trigger Anti-Cancer Responses

EAGAN, MN — March 25, 2019 — Biothera Pharmaceuticals, Inc. President and Chief Scientific Officer Jeremy Graff, Ph.D., will participate in a webinar tomorrow on the development of therapies targeting innate immune mechanisms to overcome cancer defenses and initiate anti-tumor responses.  The Scientist magazine will host the webinar, “Keeping Cancer in Check: Innate Immunity and Checkpoint Inhibitors,” from 2:30-4:00pm Eastern Time.  Registration is free. In...

Read More